Abstract:In this study, an enzymatic method is introduced that employs a recombinant endonuclease DCV fused with SpyTag to conjugate target protein antigens containing the SpyCatcher sequence with the CpG adjuvant under mild conditions. The target covalently‐linked antigen‐adjuvant complexes could induce strong and specific antibody production when administered via subcutaneous and intratracheal routes. The Toll‐like receptor 9 (TLR9) stimulator, CpG oligodeoxynucleotide, has emerged as a potent enhancer of protein subunit vaccines. Incorporating the protein antigen directly with the CpG adjuvant presents a novel strategy to significantly reduce the required dosage of CpG compared to traditional methods that use separate components. In contrast to existing chemical conjugation methods, this study introduces an enzymatic approach for antigen‐adjuvant coupling using a recombinant endonuclease DCV fused with SpyTag. This fusion protein catalyzes the covalent linkage between itself and the CpG adjuvant under mild conditions. These conjugates can be further linked with target protein antigens containing the SpyCatcher sequence, yielding stable, covalently‐linked antigen‐adjuvant complexes. The corresponding complex utilizing the receptor‐binding domain (RBD) of SARS‐CoV‐2 spike protein as the model antigen, elicits high‐titer, specific antibody production in mice via both subcutaneous administration and intratracheal inoculation. Notably, the tumor vaccine candidate fabricated by this method has also shown significant inhibition of cancer progression after intratracheal administration. The technique ensures precise, site‐specific coupling and preserves the antigen's structural integrity due to the post‐purification coupling strategy that simplifies manufacturing and aids in developing inhalable vaccines.

Epitope-Directed Antibody Elicitation by Genetically Encoded Chemical Cross-Linking Reactivity in the Antigen

Epitope-directed Antibody Selection by Site-Specific Photocrosslinking

Computational Design of an Epitope-Specific Keap1 Binding Antibody Using Hotspot Residues Grafting and CDR Loop Swapping

Polyclonal Antibody Production for Membrane Proteins via Genetic Immunization

Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation

Single-step Enzymatic Glycoengineering for the Construction of Antibody-cell Conjugates

Development of Epitopephore-Based Rational Hapten Design Strategy: A Combination of Theoretical Evidence and Experimental Validation

A Click‐Type Enzymatic Method for Antigen‐Adjuvant Conjugation

A Single-Step Chemoenzymatic Reaction for the Construction of Antibody-Cell Conjugates

Specific antibody response towards predicted epitopes of the epidermal growth factor receptor induced by a thermostable synthetic peptide adjuvant conjugate

Design Synthesis and Immunological Reaction of Epitope Peptides of ETEC K88 and K99 Fimbrial Protein

Increasing sensitivity of antibody-antigen interactions using photo-cross-linking

An Unexpected Single-step Glycosylation Enables the Construction of Antibody-Biomacromolecule Conjugates As Therapeutics

Precision engineering for localization, validation and modification of allergenic epitopes

Trimming Crystallizable Fragment (fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies As Therapeutics.

Antibody‐Directing Antibody Conjugates (ADACs) Enabled by Orthogonal Click Chemistry for Targeted Intracellular Delivery

Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome.

Spontaneous and specific chemical cross-linking in live cells to capture and identify protein interactions

Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies

Total Chemical Synthesis of Photoactivatable Proteins for Light-Controlled Manipulation of Antigen-Antibody Interactions

Genome-wide epitope identification with single-amino-acid resolution via high-throughput and unbiased peptide analysis